Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination

Vaccine

Volumn 27, Issue 38, 2009, Pages 5220-5225

  Martins, Cesario ^a   Bale, Carlitos ^a   Garly, May Lill ^a,b   Rodrigues, Amabelia ^a   Lisse, Ida M ^c   Andersen, Andreas ^a   Eriksson, Mia ^b   Benn, Christine S ^b   Whittle, Hilton ^d   Aaby, Peter ^a,b  

^a Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

^b STATENS SERUM INSTITUT   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

Maternal antibodies; Measles vaccine; Sex differences

Indexed keywords

MATERNAL ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO;

ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION PROGRAMS; INFANT; MALE; MEASLES; MEASLES VACCINE; POPULATION SURVEILLANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEX FACTORS;

EID: 67749116283     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.06.076     Document Type: Article

References (18)

1. Moraes-Pinto M.I., Verhoeff F., Chimsuku L., Milligan P.J., Wesumperuma L., Broadhead R.L., et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dias Child Fetal Neonatal Ed 79 3 (1999) F202-F205
2. Okoko B.J., Wesuperuma L.H., Ota M.O., Banya We, Pinder M., Gomez F.S., et al. Influence of placental malaria infection and maternal hypergammaglobulinaemia on maternal-foetal transfer of measles and tetanus antibodies in a rural west African population. J Health Popul Nutr 19 2 (2001) 59-65
3. Brair M.E., Brabin B.J., Milligan P., Maxwell S., and Hart C.A. Reduced transfer of tetanus antibodies with placental malaria. Lancet 343 8891 (1994) 208-209
4. Martins CL. Niveis de anticorpos contra o sarampo entre as mulheres em idade fertile na populacão expostas a sarampo natural e a imunizacão contra sarampo Osvaldo Cruz; 2002.
5. Cisse B. Measles antibody levels among women of fertile age and decay of maternal antibodies in a West African population exposed to natural measles and measles immunization. MSc thesis. London School of Hygiene and Tropical Medicine, London; 2001.
6. Jensen T.G., Whittle H., Mordhorst C.H., Pedersen I.R., Thårup J., Poulson A., et al. Trials of Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age. Vaccine 12 (1994) 1026-1031
7. Martins C.L., Garly M.L., Balé C., Rodrigues A., Ravn H., Whittle H.C., et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 337 (2008) a661 [epub]
8. Benn C.S., Aaby P., Balé C., Michaelsen K.F., Olsen J., George E., et al. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, West Africa. Lancet 350 (1997) 101-105
9. Aaby P., Lisse I.M., Whittle H., Knudsen K., Thårup J., Poulsen A., et al. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five year follow-up. Epidemiol Infect 112 (1994) 413-420
10. Benn C.S., Diness B.R., Roth A., Nante E., Fisker A.B., Lisse I.M., et al. Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 336 (2008) 1416-1420
11. Whittle H., Campbell H., Rahman S., and Armstrong J.R.M. Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine. Lancet 336 (1990) 1048-1051
12. Norrby E. Hemagglutination by measles virus. Proc Soc Exp Biol Med 111 (1962) 814-818
13. Aaby P., Bukh J., Lisse I.M., and Smits A.J. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 8 (1984) 13-21
14. Aaby P., Jensen H., Samb B., Cisse B., Sodeman M., Jakobsen M., et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: a re-analysis of the West African studies. Lancet 361 (2003) 2183-2188
15. Aaby P., Garly M.L., Balé C., Martins C., Lisse I., and Jensen H. Routine vaccinations and child survival in war situation with high mortality: effect of gender. Vaccine 21 (2002) 15-20
16. Aaby P, Martins C, Bale C, Garly ML, Rodrigues A, Biai S, Lisse IM, Whittle H, Benn CS. Sex differences in the effect of vaccines on the risk of hospitalisation due to measles in Guinea-Bissau. PIDJ. 2009 [revision].
17. Diness BR. High-dose vitamin A supplementation with Bacille Calmette-Guérin vaccine at births. PhD thesis. University of Copenhagen; 2007.
18. Fisker A.B., Lisse I.M., Aaby P., Erhardt J.G., Rodrigues A., Bibby B.M., et al. Impact of neonatal vitamin A supplementation with BCG vaccine on vitamin A status at 6 weeks and 4 months of age. Am J Clin Nutr 86 (2007) 1032-1039